Skip to content

TO EXAMINE THE EFFICACY OF BIBHITAKADI GHRIT TARPANA IN THE MANAGEMENT OF ARJUNA WITH SPECIAL REFERENCE TO SUBCONJUNCTIVAL HAEMORRHAGE.

A SINGLE ARM CLINICAL TRIAL TO ASSESS THE EFFICACY OF BIBHITAKADI GHRIT TARPANA IN THE MANAGEMENT OF ARJUNA WITH SPECIAL REFERENCE TO SUBCONJUNCTIVAL HAEMORRHAGE. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/107175
Enrollment
45
Registered
2026-03-30
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H113- Conjunctival hemorrhage

Interventions

None listed

Sponsors

Dr MADHU VITTHAL SALUNKE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Age group-18yrs to 60yrs. 2)Sex- Both Males and Females. 3)Patients with signs & symptoms of Arjuna (Subconjunctival haemorrhage) due to Trauma includede with normal fundus

Exclusion criteria

Exclusion criteria: 1) Age group below 18yrs and above 60yrs. 2)Patient suffering from infectious diseases such as Trachoma dacryocystitis, conjunctivitis,etc 3)Patient with subconjunctival haemorrhage due to HTN, Bleeding disorders like( Purpura Haemophilia and whooping cough)

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of Bibhitakadi Ghrit Tarpana in the management of Arjuna W.S.R to subconjunctival hemorrhage. Timepoint: 7 days

Secondary

MeasureTime frame
1)To study classic literature of Arjun vyadhi. 2) To study tarpanavidhi in detail. 3) To provide simple and effective treatment for arjuna vyadhi.Timepoint: 7days

Countries

India

Contacts

Public ContactDr MADHU VITTHAL SALUNKE

LATE KEDARI REDEKAR AYURVEDIC MAHAVIDYALAYA AND RESEARCH CENTRE

dr.poonam2785@gmail.com8605657046

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026